Health Care & Life Sciences » Pharmaceuticals | Fuso Pharmaceutical Industries Ltd.

Fuso Pharmaceutical Industries Ltd. | Income Statement

Fiscal year is April-March. All values JPY Millions.
2014
2015
2016
2017
2018
2019
Sales/Revenue
49,098
47,042
45,752
46,782
45,900
46,074
Cost of Goods Sold (COGS) incl. D&A
34,859
34,510
33,600
34,083
33,123
33,147
Gross Income
14,239
12,532
12,152
12,699
12,777
12,927
SG&A Expense
11,444
11,736
11,856
12,042
11,978
11,665
EBIT
2,797
796
296
657
799
1,262
Unusual Expense
-
76
94
67
113
113
Non Operating Income/Expense
81
14
103
497
621
44
Interest Expense
239
222
226
222
220
226
Pretax Income
2,649
652
117
1,061
1,361
1,255
Income Tax
670
312
107
200
391
361
Consolidated Net Income
1,979
340
10
861
970
894
Net Income
1,979
340
10
861
970
894
Net Income After Extraordinaries
1,979
340
10
861
970
894
Net Income Available to Common
1,979
340
10
861
970
894
EPS (Basic)
218.70
37.60
1.10
95.83
109.60
101.86
Basic Shares Outstanding
9
9
9
9
9
9
EPS (Diluted)
218.66
37.58
1.11
95.83
109.60
101.86
Diluted Shares Outstanding
9
9
9
9
9
9
EBITDA
4,675
2,710
1,809
2,661
2,720
3,229
Other Operating Expense
2
-
-
-
-
-
Non-Operating Interest Income
10
16
56
62
20
20
Equity in Affiliates (Pretax)
-
-
-
-
27
43

About Fuso Pharmaceutical Industries

View Profile
Address
2-3-11 Morinomiya
Osaka Osaka 536
Japan
Employees -
Website http://www.fuso-pharm.co.jp
Updated 07/08/2019
Fuso Pharmaceutical Industries, Ltd. engages in the manufacture and sale of ethical pharmaceutical and medical equipment. It operates through the Pharmaceuticals and Real Estate divisions. The Pharmaceuticals division deals with the manufacture and sale of pharmaceutical products which mainly focus on prescription drugs.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.